Found 11 matching trials
PK of Depo SubQ Injected in the Upper Arm
NAA single-arm trial to demonstrate that Depo-SubQ Provera injected in the up...
Location
Clinical Research Center, Dept. of Obstetrics & Gynegology, Eastern Virginia Medical School
Self Administration of Subcutaneous Depot Medroxyprogesterone Acetate
N/AThe purpose of this study is to assess continuation rates and patient satis...
Location
Planned Parenthood of Southwest and Central Florida
A Study to Evaluate Injection Pain and Local Tolerability Following Subcutaneous (SC) Administration of TV-46046
PHASE1The purpose of this study is to evaluate the local tolerability associated ...
Location
Teva Investigational Site 1
Lower Dose Depo Provera® Contraceptive Injection
PHASE1This is a randomized, partially-blinded, multi-center, parallel-group study...
Location
Universidade Estadual de Campinas (UNICAMP)
Depo Provera Self-Administration Study: Putting a Patient-Centered Practice to the Test at Planned Parenthood
PHASE4This randomized clinical trial will study subcutaneous depot medroxyprogest...
Location
Planned Parenthood of Central and Greater Northern New Jersey
Study of Self or Clinic Administration of DepoProvera
NADepot medroxyprogesterone acetate (DepoProvera) is an acceptable form of co...
Location
Columbia University/New York Presbyterian Hospital
Acceptability of Depo-subQ Provera 104 in Uniject vs. Intramuscular Depo-Provera Among HIV+ Women & Providers, Uganda
NAThe purpose of this study is to assess acceptability and side effects of a ...
Location
Rakai Health Sciences Program
Elagolix Versus Subcutaneous Depot Medroxyprogesterone Acetate for the Treatment of Endometriosis
PHASE2This study is designed to assess the effects of elagolix versus subcutaneou...
Location
Multiple Locations
A Study to Evaluate the Pharmacokinetics (PK) of Medroxyprogesterone Acetate Following an Injection of TV-46046 in Healthy Women of Reproductive Age
PHASE1The primary objective of this study is to evaluate and compare the pharmaco...
Location
Teva Investigational Site 14002
Long-Acting Reversible Contraception
PHASE4In the proposed study, women aged 18-29 seeking oral or injectable contrace...
Location
Planned Parenthood Central North Carolina